Jian Sun

Corporate Officer/Principal presso Lianyuangang Chia Tai Tianqing Medicine Co., Ltd.

62 anni

Health Technology

Profilo

Jian Sun is currently the General Manager at Lianyuangang Chia Tai Tianqing Medicine Co., Ltd.
Prior to this, he was the President at Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Posizioni attive di Jian Sun

Società	Posizione	Inizio
Lianyuangang Chia Tai Tianqing Medicine Co., Ltd.	Corporate Officer/Principal	19/08/2011

Tutte le posizioni attive di Jian Sun

Precedenti posizioni note di Jian Sun

Società	Posizione	Fine
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The company was founded in 1969, and the CEO is Kang Xin Yu.	Presidente	-

Vedi nel dettaglio l'esperienza di Jian Sun

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jian Sun

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The company was founded in 1969, and the CEO is Kang Xin Yu.	Health Technology
Lianyuangang Chia Tai Tianqing Medicine Co., Ltd.